Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats.

Many possible treatments for pulmonary fibrosis have been investigated, but except for some current clinical trials, none have succeeded in clinical trials. On the basis of the antioxidant action of bilirubin (BIL), we examined the effects of hyperbilirubinemia on the development of bleomycin (BLM)-induced pulmonary fibrosis in rats. The animals' plasma BIL level was kept within 3 and 10 mg/dl by repeated intravenous infusion of a high dose of BIL. We studied the inhibitory effects of hyperbilirubinemia on BLM-induced pulmonary fibrosis through histopathologic and biochemical analyses. Mortality of rats with BLM-induced pulmonary fibrosis was significantly lower in the three groups with hyperbilirubinemia. The ameliorating effect of hyperbilirubinemia on pulmonary fibrosis was shown by lung histology, as well as by a decreased lung content of hydroxyproline and reduced bronchoalveolar lavage fluid (BALF) concentration of transforming growth factor (TGF)-beta(1). The number of polymorphonuclear leukocytes and lymphocytes in BALF was also decreased in the groups with hyperbilirubinemia. Furthermore, oxidative metabolites of BIL in urine were present at significantly higher levels in BLM-treated rats with hyperbilirubinemia than in those without hyperbilirubinemia. These data suggest that the antioxidative action of BIL can attenuate BLM-induced pulmonary fibrosis, partly by inhibiting lung inflammation and production of TGF-beta1.

[1]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[2]  P. Dennery,et al.  Antioxidant and Cytotoxic Effects of Bilirubin on Neonatal Erythrocytes , 1999, Pediatric Research.

[3]  R. Prior,et al.  Comparison of different analytical methods for assessing total antioxidant capacity of human serum. , 1998, Clinical chemistry.

[4]  D. Pietraforte,et al.  Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. , 1998, Archives of biochemistry and biophysics.

[5]  H. Schwertner.  Association of smoking and low serum bilirubin antioxidant concentrations. , 1998, Atherosclerosis.

[6]  M. Yamakido,et al.  Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. , 1997, American journal of respiratory and critical care medicine.

[7]  P. Opolon,et al.  Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. , 1997, The Journal of clinical investigation.

[8]  H. Nakajima,et al.  Epitope of 24G7 anti-bilirubin monoclonal antibody. , 1996, Biochimica et biophysica acta.

[9]  D. Stevenson,et al.  Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. , 1995, Free radical biology & medicine.

[10]  C. Vogelmeier,et al.  Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. , 1995, The European respiratory journal.

[11]  H. Nakajima,et al.  Chemical structure of a new family of bile pigments from human urine. , 1994, Journal of biochemistry.

[12]  H. Magnussen,et al.  The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. , 1994, The European respiratory journal.

[13]  A. Nehlig,et al.  Effects of bilirubin infusion on local cerebral glucose utilization in the immature rat. , 1993, Brain research. Developmental brain research.

[14]  T. Kinoshita,et al.  A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. , 1993, Biochimica et biophysica acta.

[15]  D. Hyde,et al.  Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. , 1993, Thorax.

[16]  D. Danielpour,et al.  Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. , 1993, The Journal of clinical investigation.

[17]  K. Aoshiba,et al.  Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. , 1992, The American review of respiratory disease.

[18]  K. Flanders,et al.  Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.

[19]  T. Colby,et al.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. McAnulty,et al.  Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. , 1991, The European respiratory journal.

[21]  A. Kang,et al.  Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. , 1989, The Journal of clinical investigation.

[22]  M. Sporn,et al.  Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation , 1989, The Journal of experimental medicine.

[23]  J M Simpson,et al.  Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.

[24]  J. Lazo,et al.  High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. , 1987, The Journal of pharmacology and experimental therapeutics.

[25]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[26]  D. Hill,et al.  Bi‐functional action of transforming growth factor‐β on DNA synthesis in early passage human fetal fibroblasts , 1986, Journal of cellular physiology.

[27]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[28]  D. Hyde,et al.  Analysis of Bronchoalveolar Lavage Fluid from Bleomycin-Induced Pulmonary Fibrosis in Hamsters , 1986, Toxicologic pathology.

[29]  D. Hyde,et al.  Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. , 1983, The American journal of pathology.

[30]  I. Fridovich,et al.  A reaction of the superoxide radical with tetrapyrroles. , 1982, Archives of biochemistry and biophysics.

[31]  P. Ward,et al.  Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. , 1979, The American journal of pathology.

[32]  B. Stevens,et al.  THE PHOTOPEROXIDATION OF UNSATURATED ORGANIC MOLECULES—XV. O2 1 δg QUENCHING BY BILIRUBIN AND BILIVERDIN , 1976, Photochemistry and photobiology.

[33]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[35]  H. Cottier,et al.  Cellular events in alveolitis and the evolution of pulmonary fibrosis , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[36]  S. Phan,et al.  Oxygen metabolite detoxifying enzyme levels in bleomycin-induced fibrotic lungs. , 1988, Free radical biology & medicine.

[37]  I. Horváth,et al.  Bile pigments inhibit microsomal lipid peroxidation. , 1986, Acta biochimica et biophysica Hungarica.

[38]  F. Oski,et al.  Hematologic problems in the newborn. , 1972, Major problems in clinical pediatrics.